Cortistatin
Cortistatin is an endogenous peptide with established physiological or receptor-level biology; therapeutic administration and indications are molecule-specific.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence4/5
Evidence Snapshot
- Overall
- 0/5None identified
- Human
- 0/5None identified
- Animal
- 0/5None identified
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Peptide family
- Endogenous signalling peptide
- Entity class
- Endogenous peptide
Cortistatin entered research or commercial use through work on its proposed biological, cosmetic or therapeutic activity.
Proposed Mechanisms
- not-yet-documentedpending-editorial-review
Reported / Studied Uses
Human Evidence
Human studies support physiological relevance, but evidence for exogenous use varies by indication.
Animal Evidence
Animal studies broaden understanding of receptor, metabolic, neural or cardiovascular functions.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.